Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ENTA

Enanta Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · ENTA

All alert types
10.71 USD -0.44 -3.95%
As of Oct 30, 2026 Extended hours 10.71 0.00%
Bid
10.77 × 2
Ask
10.78 × 2
10.71 Day range 11.09
10.71 52-week range 16.85
YTD
-32.09%
1 year
-1.38%
Open
11.05
Prev close
11.15
Mkt cap
311.93M
Vol
202.34K
Avg vol
247.71K
EPS
-2.42
P/E
0.00
Div yield
0.00%
More statistics
Low
10.71
High
11.09
Forward P/E
-1.32
Beta
0.57
Short ratio
20.91
Inst. own
100.66%
Dividend
0.00
Ex-div date
Earnings
Feb 5, 2025
50-d avg
9.78
200-d avg
12.44
1y target
16.88

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ENTA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.90 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -3.1×
FY 2016: 23.3×FY 2017: 50.3×FY 2018: 24.2×FY 2019: 25.4×FY 2020: -25.3×FY 2021: -14.5×FY 2022: -8.8×FY 2023: -1.8×FY 2024: -1.9×FY 2025: -3.1×
FY 2016 5y median -3.1× FY 2025
P/S 3.9×
FY 2016: 5.7×FY 2017: 8.7×FY 2018: 8.4×FY 2019: 5.7×FY 2020: 7.5×FY 2021: 11.8×FY 2022: 12.4×FY 2023: 3.0×FY 2024: 3.2×FY 2025: 3.9×
FY 2016 5y median 3.9× FY 2025
P/B 3.9×
FY 2016: 1.9×FY 2017: 3.0×FY 2018: 4.4×FY 2019: 2.5×FY 2020: 2.0×FY 2021: 2.9×FY 2022: 3.3×FY 2023: 1.1×FY 2024: 1.7×FY 2025: 3.9×
FY 2016 5y median 2.9× FY 2025
P/FCF -7.9×
FY 2016: 16.2×FY 2017: 17.8×FY 2018: 66.2×FY 2019: 17.8×FY 2020: 162×FY 2021: -16.2×FY 2022: -12.3×FY 2023: -2.1×FY 2024: -2.3×FY 2025: -7.9×
FY 2016 5y median -7.9× FY 2025
EV/EBITDA -6.0×
FY 2016: 15.0×FY 2017: 30.9×FY 2018: 18.4×FY 2019: 28.1×FY 2020: -22.0×FY 2021: -10.5×FY 2022: -8.8×FY 2023: -1.4×FY 2024: -3.9×FY 2025: -6.0×
FY 2016 5y median -6.0× FY 2025
EV/Sales 6.5×
FY 2016: 5.5×FY 2017: 8.0×FY 2018: 8.1×FY 2019: 5.5×FY 2020: 6.8×FY 2021: 11.3×FY 2022: 12.2×FY 2023: 2.2×FY 2024: 6.0×FY 2025: 6.5×
FY 2016 5y median 6.5× FY 2025
FCF Yield -12.6%
FY 2016: 6.2%FY 2017: 5.6%FY 2018: 1.5%FY 2019: 5.6%FY 2020: 0.6%FY 2021: -6.2%FY 2022: -8.1%FY 2023: -47.9%FY 2024: -44.1%FY 2025: -12.6%
FY 2016 5y median -12.6% FY 2025

Profitability

Gross Margin 93.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 93.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -130.7%
FY 2016: 34.9%FY 2017: 23.9%FY 2018: 42.7%FY 2019: 17.9%FY 2020: -34.0%FY 2021: -112.9%FY 2022: -143.7%FY 2023: -173.2%FY 2024: -179.9%FY 2025: -130.7%
FY 2016 5y median -143.7% FY 2025
Net Margin -125.4%
FY 2016: 24.5%FY 2017: 17.2%FY 2018: 34.8%FY 2019: 22.6%FY 2020: -29.5%FY 2021: -81.4%FY 2022: -141.3%FY 2023: -169.0%FY 2024: -171.6%FY 2025: -125.4%
FY 2016 5y median -141.3% FY 2025
ROE -126.5%
FY 2016: 8.0%FY 2017: 5.9%FY 2018: 18.3%FY 2019: 10.0%FY 2020: -7.9%FY 2021: -19.8%FY 2022: -37.9%FY 2023: -61.7%FY 2024: -90.1%FY 2025: -126.5%
FY 2016 5y median -61.7% FY 2025
ROIC -31.4%
FY 2016: 7.5%FY 2017: 5.3%FY 2018: 17.1%FY 2019: 7.9%FY 2020: -8.8%FY 2021: -19.7%FY 2022: -34.9%FY 2023: -33.9%FY 2024: -33.8%FY 2025: -31.4%
FY 2016 5y median -33.8% FY 2025
ROA -29.2%
FY 2016: 7.7%FY 2017: 5.4%FY 2018: 17.4%FY 2019: 9.5%FY 2020: -7.4%FY 2021: -17.9%FY 2022: -32.0%FY 2023: -28.9%FY 2024: -30.8%FY 2025: -29.2%
FY 2016 5y median -29.2% FY 2025

Growth (YoY)

Revenue -3.4%
FY 2016: -45.1%FY 2017: 16.5%FY 2018: 101.0%FY 2019: -0.7%FY 2020: -40.3%FY 2021: -20.7%FY 2022: -11.2%FY 2023: -8.1%FY 2024: -14.6%FY 2025: -3.4%
FY 2016 FY 2025
Operating Income 29.9%
FY 2016: -75.2%FY 2017: -20.2%FY 2018: 258.9%FY 2019: -58.4%FY 2020: -213.3%FY 2021: -163.1%FY 2022: -13.0%FY 2023: -10.8%FY 2024: 11.3%FY 2025: 29.9%
FY 2016 FY 2025
EPS (diluted) 29.9%
FY 2016: -72.4%FY 2017: -19.5%FY 2018: 282.4%FY 2019: -36.5%FY 2020: -181.9%FY 2021: -116.6%FY 2022: -50.8%FY 2023: -8.0%FY 2024: 14.1%FY 2025: 29.9%
FY 2016 FY 2025
Free Cash Flow 66.7%
FY 2016: -58.2%FY 2017: 61.4%FY 2018: -47.7%FY 2019: 151.5%FY 2020: -91.5%FY 2021: -1353.7%FY 2022: -22.8%FY 2023: -29.1%FY 2024: 13.8%FY 2025: 66.7%
FY 2016 FY 2025

Financial Health

Current Ratio 4.2×
FY 2016: 29.4×FY 2017: 11.3×FY 2018: 23.7×FY 2019: 17.8×FY 2020: 18.1×FY 2021: 8.8×FY 2022: 10.5×FY 2023: 6.7×FY 2024: 5.2×FY 2025: 4.2×
FY 2016 5y median 6.7× FY 2025
Quick Ratio 4.2×
FY 2016: 29.4×FY 2017: 11.3×FY 2018: 23.7×FY 2019: 17.8×FY 2020: 18.1×FY 2021: 8.8×FY 2022: 10.5×FY 2023: 6.7×FY 2024: 5.2×FY 2025: 4.2×
FY 2016 5y median 6.7× FY 2025
Debt / Equity 3.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 1.8×FY 2025: 3.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -2.4×
FY 2016: -0.5×FY 2017: -2.4×FY 2018: -0.7×FY 2019: -1.3×FY 2020: 2.0×FY 2021: 0.5×FY 2022: 0.1×FY 2023: 0.5×FY 2024: -1.8×FY 2025: -2.4×
FY 2016 5y median 0.1× FY 2025
Interest Coverage -11.1×
FY 2016: 685×FY 2017: 615×FY 2018: 18.2×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -26.7×FY 2024: -11.1×FY 2025: -11.1×
FY 2016 5y median -11.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30